This survival advantage is associated with decreased pneumonia-induced intestinal atrophy and epithelial apoptosis, preservation of the intestinal proliferative response, and a reduction in circulating levels of the proinflammatory cytokines IL-6 and G-CSF. The gene discussed is IL6; the disease is pneumonia.